Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Wieser R"" wg kryterium: Wszystkie pola


Tytuł :
Investigation of the magnetic phase diagram of the 2D ferrimagnetic J1–J2 model.
Autorzy :
Wieser, R
Pokaż więcej
Źródło :
Journal of Physics: Condensed Matter; 3/3/2021, Vol. 33 Issue 9, p1-8, 8p
Czasopismo naukowe
Tytuł :
Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness.
Autorzy :
Grandits AM; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Nguyen CH; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Schlerka A; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Hackl H; Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
Sill H; Division of Hematology, Medical University of Graz, Graz, Austria.
Etzler J; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Heyes E; Institute for Medical Biochemistry, University of Veterinary Medicine, Vienna, Austria.
Stoiber D; Division of Pharmacology, Department of Pharmacology, Physiology and Microbiology, Karl Landsteiner University of Health Sciences, Krems, Austria.
Grebien F; Institute for Medical Biochemistry, University of Veterinary Medicine, Vienna, Austria.
Heller G; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Wieser R; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. rotraud.wieser@meduniwien.ac.at.; Comprehensive Cancer Center, Vienna, Austria. rotraud.wieser@meduniwien.ac.at.
Pokaż więcej
Źródło :
Leukemia [Leukemia] 2021 Mar 29. Date of Electronic Publication: 2021 Mar 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A.
Autorzy :
Grandits AM; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, Vienna, Austria.
Wieser R; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Comprehensive Cancer Center, Vienna, Austria. Electronic address: rotraud.wieser@meduniwien.ac.at.
Pokaż więcej
Źródło :
Experimental hematology [Exp Hematol] 2021 Jul; Vol. 99, pp. 1-11. Date of Electronic Publication: 2021 May 21.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Peter Poiret, der Vater der romanischen Mystik in Deutschland (Volume II de la série : Mystiker des Abendlandes) Max Wieser R. F. Merkel
Autorzy :
Salomon A.
Pokaż więcej
Źródło :
Bulletin de la Société de l'Histoire du Protestantisme Français (1903-). 82(4):533-536
Relacje :
Peter Poiret, der Vater der romanischen Mystik in Deutschland (Volume II de la série : Mystiker des Abendlandes) Max Wieser R. F. Merkel
Dostęp URL :
https://www.jstor.org/stable/24291123
Recenzja
Tytuł :
Streptokokkenmediastinitis nach Thyreoidektomie: Eine Literaturübersicht
Autorzy :
Bures, C.
Zielinski, V.
Klatte, T.
Swietek, N.
Kober, F.
Tatzgern, E.
Bobak-Wieser, R.
Gschwandtner, E.
Gilhofer, M.
Wechsler-Fördös, A.
Hermann, M.
Pokaż więcej
Alternatywny tytuł :
Streptococcal mediastinitis after thyroidectomy: A literature review
Źródło :
Der Chirurg: Zeitschrift für alle Gebiete der operativen Medizin. December 2015 86(12):1145-1150
Czasopismo naukowe
Tytuł :
IL2RA Promotes Aggressiveness and Stem Cell-Related Properties of Acute Myeloid Leukemia.
Autorzy :
Nguyen CH; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. .wieser@meduniwien.ac.at.; Comprehensive Cancer Center, Vienna, Austria.
Schlerka A; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Grandits AM; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Koller E; 3rd Medical Department, Hanusch Hospital, Vienna, Austria.
van der Kouwe E; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Vassiliou GS; Wellcome Medical Research Council Cambridge Stem Cell Institute, Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
Staber PB; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Heller G; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Wieser R; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria. .wieser@meduniwien.ac.at.; Comprehensive Cancer Center, Vienna, Austria.
Pokaż więcej
Źródło :
Cancer research [Cancer Res] 2020 Oct 15; Vol. 80 (20), pp. 4527-4539. Date of Electronic Publication: 2020 Sep 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Interleukin-2 Receptor alpha Subunit/*genetics
Leukemia, Myeloid, Acute/*genetics
Leukemia, Myeloid, Acute/*pathology
Animals ; Antibodies, Monoclonal/pharmacology ; Apoptosis/genetics ; Case-Control Studies ; Cell Line, Tumor ; Cell Proliferation/genetics ; Female ; Gene Expression Regulation, Leukemic ; Humans ; Interleukin-2 Receptor alpha Subunit/immunology ; Leukemia, Myeloid, Acute/drug therapy ; Leukemia, Myeloid, Acute/mortality ; Mice, Inbred C57BL ; Prognosis ; Stem Cells/pathology ; fms-Like Tyrosine Kinase 3/genetics
Czasopismo naukowe
Tytuł :
All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells.
Autorzy :
Nguyen CH; Division of Oncology, Department of Medicine I, Medical University of Vienna , Vienna, Austria.; Comprehensive Cancer Center , Vienna, Austria.
Grandits AM; Division of Oncology, Department of Medicine I, Medical University of Vienna , Vienna, Austria.; Comprehensive Cancer Center , Vienna, Austria.
Purton LE; Stem Cell Regulation Unit, St. Vincent's Institute of Medical Research and Department of Medicine at St. Vincent's Hospital, The University of Melbourne , Melbourne, Australia.
Sill H; Division of Hematology, Medical University of Graz , Graz, Austria.
Wieser R; Division of Oncology, Department of Medicine I, Medical University of Vienna , Vienna, Austria.; Comprehensive Cancer Center , Vienna, Austria.
Pokaż więcej
Źródło :
Cell cycle (Georgetown, Tex.) [Cell Cycle] 2020 Oct; Vol. 19 (20), pp. 2573-2588. Date of Electronic Publication: 2020 Sep 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Evi1 Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of All-Trans Retinoic Acid on Flt3 -ITD/ Npm1c -Driven Acute Myeloid Leukemia Cells.
Autorzy :
Nguyen CH; Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center, 1090 Vienna, Austria.
Grandits AM; Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center, 1090 Vienna, Austria.
Vassiliou GS; Wellcome Medical Research Council Cambridge Stem Cell Institute, Department of Haematology, University of Cambridge, Cambridge CB2 0AW, UK.
Staber PB; Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
Heller G; Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center, 1090 Vienna, Austria.
Wieser R; Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Cancer Center, 1090 Vienna, Austria.
Pokaż więcej
Źródło :
Biomedicines [Biomedicines] 2020 Sep 28; Vol. 8 (10). Date of Electronic Publication: 2020 Sep 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Role of miR-96/EVI1/miR-449a Axis in the Nasopharyngeal Carcinoma Cell Migration and Tumor Sphere Formation.
Autorzy :
Chan LS; Department of Biology, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China.
Lung HL; Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China.
Ngan RK; Department of Clinical Oncology, University of Hong Kong, Pokfulam, Hong Kong, China.; Center for Nasopharyngeal Carcinoma Research, University of Hong Kong, Pokfulam, Hong Kong, China.
Lee AW; Department of Clinical Oncology, University of Hong Kong, Pokfulam, Hong Kong, China.; Center for Nasopharyngeal Carcinoma Research, University of Hong Kong, Pokfulam, Hong Kong, China.
Tsao SW; Center for Nasopharyngeal Carcinoma Research, University of Hong Kong, Pokfulam, Hong Kong, China.; Department of Anatomy, University of Hong Kong, Pokfulam, Hong Kong, China.
Lo KW; Department of Anatomical and Cellular Pathology and State Key Laboratory in Oncology in South China, The Chinese University of Hong Kong, Central Ave, Hong Kong, China.
Kahn M; Department of Molecular Medicine, Beckman Research Institute at City of Hope, Duarte, CA 91010-3000, USA.
Lung ML; Department of Clinical Oncology, University of Hong Kong, Pokfulam, Hong Kong, China.; Center for Nasopharyngeal Carcinoma Research, University of Hong Kong, Pokfulam, Hong Kong, China.
Wieser R; Division of Oncology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
Mak NK; Department of Biology, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China.; Center for Nasopharyngeal Carcinoma Research, University of Hong Kong, Pokfulam, Hong Kong, China.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2020 Jul 31; Vol. 21 (15). Date of Electronic Publication: 2020 Jul 31.
Typ publikacji :
Journal Article
MeSH Terms :
MDS1 and EVI1 Complex Locus Protein/*genetics
MicroRNAs/*genetics
Nasopharyngeal Carcinoma/*genetics
3' Untranslated Regions ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Nasopharyngeal Carcinoma/pathology ; Neoplastic Stem Cells/metabolism ; Wnt Signaling Pathway/genetics
Czasopismo naukowe
Tytuł :
All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia.
Autorzy :
Nguyen CH; Division of Oncology, Clinic of Medicine I, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Bauer K; Division of Oncology, Clinic of Medicine I, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Hackl H; Division of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
Schlerka A; Division of Oncology, Clinic of Medicine I, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Vienna, Austria.
Koller E; Medical Department for Leukemia Research and Hematology, Hanusch Hospital, Vienna, Austria.
Hladik A; Research Laboratory of Infection Biology, Clinic of Medicine I, Medical University of Vienna, Vienna, Austria.
Stoiber D; Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria.; Institute of Pharmacology, Medical University of Vienna, Vienna, Austria.
Zuber J; Institute of Molecular Pathology, Vienna, Austria.
Staber PB; Division of Hematology and Hemostaseology, Clinic of Medicine I, Medical University of Vienna, Vienna, Austria.
Hoelbl-Kovacic A; Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria.
Purton LE; Stem Cell Regulation Unit, St. Vincent's Institute of Medical Research and Department of Medicine at St. Vincent's Hospital, The University of Melbourne, Melbourne, Australia.
Grebien F; Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria.; Institute of Medical Biochemistry, University of Veterinary Medicine, Vienna, Austria.
Wieser R; Division of Oncology, Clinic of Medicine I, Medical University of Vienna, Vienna, Austria. rotraud.wieser@meduniwien.ac.at.; Comprehensive Cancer Center, Vienna, Austria. rotraud.wieser@meduniwien.ac.at.
Pokaż więcej
Źródło :
Cell death & disease [Cell Death Dis] 2019 Dec 10; Vol. 10 (12), pp. 944. Date of Electronic Publication: 2019 Dec 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Leukemia, Myeloid, Acute/*genetics
MDS1 and EVI1 Complex Locus Protein/*genetics
Receptor, Notch4/*genetics
Tretinoin/*metabolism
Animals ; Apoptosis/drug effects ; Carcinogenesis/drug effects ; Cell Proliferation/drug effects ; Disease Models, Animal ; Gene Expression Regulation, Leukemic/drug effects ; Humans ; Leukemia, Myeloid, Acute/pathology ; Mice ; Myeloid Cells/drug effects ; Neoplastic Stem Cells/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies